amend

AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug – Proactive Investors USA & Canada

Proactive Investors USA & Canada AstraZeneca, Dynavax amend agreement to accelerate development of asthma drugProactive Investors USA & CanadaAstraZeneca (NYSE:AZN) and Dynavax Technologies (NASDAQ:DVAX) announced Wednesday they have amended their collaboration agreement so as to accelerate the development of AZD1419,…